Culture & Entertainment · India Bureau
Brazilian pit viper venom led to breakthrough blood pressure drug
A peptide discovered in the venom of the Brazilian pit viper in the 1960s became the foundation for captopril, a groundbreaking medication that revolutionised the treatment of hypertension and heart disease. The discovery emerged from research that would ultimately transform cardiovascular medicine worldwide.
LSN India ·
Researchers studying the venom of Bothrops jararaca, commonly known as the Brazilian pit viper, made a pivotal discovery in the 1960s that would reshape cardiovascular treatment. Scientist Sergio Ferreira identified a peptide within the snake's venom that demonstrated a remarkable ability to regulate blood pressure in the human body.
Ferreira's findings provided crucial insight into the mechanisms controlling blood pressure, leading researchers to develop new therapeutic approaches. The peptide discovery offered a novel pathway for understanding and managing hypertension, conditions that had long challenged the medical community.
Building on this foundation, researchers synthesised captopril, an ACE inhibitor that received regulatory approval in 1981. The drug represented a paradigm shift in cardiovascular medicine, offering patients a more effective treatment option for hypertension and heart-related conditions.
Captopril's success demonstrated how compounds found in nature, even from unexpected sources such as snake venom, could yield significant medical applications. The medication became widely adopted globally and remains a testament to the value of exploratory scientific research and its real-world health benefits for millions of patients managing cardiovascular conditions.